He is Head of The Centre for the Study of Immunology at Trinity Biomedical Sciences Institute and Theme Champion for Immunology, Inflammation and Infection at TCD. He is a graduate of TCD and trained at as a Postdoctoral Fellow at University College London and the National Institute for Medical Research, Mill Hill, London, before joining the Scientific Staff of NIBSC, Herts, UK. He returned to Ireland in 1993 to take up an academic position at National University of Ireland, Maynooth. He was appointed to a Personal Chair at Trinity College Dublin in 2001 and was Head of the School of Biochemistry and Immunology from 2008-2011. He heads an active research team focusing on T cells in infection, autoimmunity and cancer. He is co-founder of Opsona Therapeutics and TriMod Therapeutics, biotech companies focusing on the development of immunotherapeutics for inflammatory diseases and cancer.
"Novartis are delighted to continue to support the Future Health Summit. The event is always high quality from its organisation to its speakers, and is a must attend event for anyone with an interest in improving healthcare and outcomes for patients"Ian Addie, Patient Access Head, Novartis Ireland Ltd
"‘Irish Heart would like to extend our thanks for having our mobile health unit attend the Future Health Summit. The mobile health unit was extremely well received and there was over 130 blood pressure checks taken over the two days,. The event was fantastic."Emma Carter ,Mobile Health Unit Manager ,Irish Heart
"‘I have spoken at and attended this event for the last six years and in a short space of time the Future Health Summit has become an annual meeting place for progressive healthcare leaders who want to drive change and improve healthcare delivery. "Mr. Bill Maher, Chief Executive, Bon Secours Health System
"“This Conference is another one of Ireland’s global contributions. The Future Health Summit is required attendance for all who wish to engage in a stimulating interchange on the future of healthcare – globally and domestically""Michael Dowling , Chief Executive Officer of Northwell Health